Americans who want to retire abroad often cite the high cost of medicine as a driving factor. In many other countries, prescriptions are available for free or at a low, subsidized cost to residents. These prices are thanks to governments using their collective buying power to drive down the costs of life-saving medications.

AARP just released a list of the 25 brand-name drugs with the highest-total Medicare Part D spending, and found that, “List prices for the top 25 drugs have increased by an average of 226 percent—or more than tripled—since they first entered the market. These lifetime price increases ranged from 20 percent to 739 percent.”

AARP also notes that, “One in five older adults report engaging in cost-coping strategies such as not filling a prescription or skipping doses to save money on their prescription medications.”

Read on to see the 25 medications and how they’ve increased in price compared to inflation.

25. Stelara

Stelara (released in 2009) treats Crohn’s disease.

• Price increase: 184%
• Inflation during the same time period: 41%

24. Pomalyst

Pomalyst (released in 2013) treats multiple myeloma.

• Price increase: 102%
• Inflation during the same time period: 30%

23. Restasis

Restasis (released in 2002) treats chronic dry eye.

• Price increase: 330%
• Inflation during the same time period: 66%

22. Entresto

Entresto (released in 2015) treats long-lasting (chronic) heart failure.

• Price increase: 78%
• Inflation during the same time period: 27%

21. Victoza

Victoza (released in 2010) treats type 2 diabetes.

• Price increase: 209%
• Inflation during the same time period: 40%

20. Levemir

Levemir (released in 2005) treats diabetes.

• Price increase: 360%
• Inflation during the same time period: 52%

19. Ibrance

Ibrance (released in 2015) treats breast cancer.

• Price increase: 53%
• Inflation during the same time period: 29%

18. Invega

Invega (released in 2009) treats schizophrenia and schizoaffective disorder.

• Price increase: 126%
• Inflation during the same time period: 41%

17. Myrbetriq

Myrbetriq (released in 2012) treats overactive bladder.

• Price increase: 114%
• Inflation during the same time period: 32%

16. Symbicort

Symbicort (released in 2006) treats chronic obstructive pulmonary disease (COPD).

• Price increase: 158%
• Inflation during the same time period: 47%

15. Biktarvy

Biktarvy (released in 2018) treats HIV/AIDS.

• Price increase: 29%
• Inflation during the same time period: 22%

14. Enbrel

Enbrel (released in 1998) treats autoimmune diseases.

• Price increase: 701%
• Inflation during the same time period: 85%

13. Trelegy Ellipta

Trelegy Ellipta (released in 2017) treats chronic obstructive pulmonary disease (COPD). It’s the only medicine on the list whose price rose slower than inflation.

• Price increase: 20%
• Inflation during the same time period: 23%

12. Xtandi

Xtandi (released in 2012) treats prostate cancer.

• Price increase: 83%
• Inflation during the same time period: 32%

11. Novolog

Novolog (released in 2000) treats diabetes.

• Price increase: 628%
• Inflation during the same time period: 71%

10. Ozempic

Ozempic (released in 2017) treats type 2 diabetes.

• Price increase: 38%
• Inflation during the same time period: 22%

9. Imbruvica

Imbruvica (released in 2013) treats chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

• Price increase: 108%
• Inflation during the same time period: 30%

8. Jardiance

Jardiance (released in 2014) treats type 2 diabetes.

• Price increase: 97%
• Inflation during the same time period: 28%

7. Lantus

Lantus (released in 2000) treats diabetes.

• Price increase: 739%
• Inflation during the same time period: 71%

6. Januvia

Januvia (released in 2006) treats type 2 diabetes.

• Price increase: 275%
• Inflation during the same time period: 50%

5. Trulicity

Trulicity (released in 2014) treats type 2 diabetes.

• Price increase: 81%
• Inflation during the same time period: 28%

4. Humira

Humira (released in 2002) treats arthritis, plaque psoriasis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis.

• Price increase: 562%
• Inflation during the same time period: 66%

3. Xarelto

Xarelto (released in 2011) is a blood thinner.

• Price increase: 168%
• Inflation during the same time period: 35%

2. Revlimid

Revlimid (released in 2005) treats multiple myeloma.

• Price increase: 270%
• Inflation during the same time period: 53%

1. Eliquis

Eliquis (released in 2012) is a blood thinner.

• Price increase: 124%
• Inflation during the same time period: 31%

14 Countries with Better Healthcare Than the United States

In some cases, countries have much better outcomes than the United States, and in others, countries have marginally worse outcomes but much more affordable, accessible care. Learn about 14 countries with better healthcare than the US where you can immigrate.

➤ 14 Countries with Better Healthcare Than the United States

10 Countries Where You Can Retire With $2,000/Month

Are you looking forward to retirement? Do you imagine peaceful days spent socializing with family and friends, pursuing hobbies, and catching up on things you put off during a long career with limited time off?

While we all long for those days, you may look at your bank account and bills and wonder if they’ll ever come. If retiring in the U.S. feels unattainable, there are options for moving abroad that may be within your budget.

➤ 10 Countries Where You Can Retire With $2,000/Month

Medicare Co-Pays Slashed on 13 Drugs: See if You’ll Save

Biden’s Inflation Reduction Act is putting money in seniors’ pockets quicker than expected. A federal judge has already sided with the plan, agreeing that the government can negotiate prices for Americans.

It looks like Medicare’s drug insurers see the writing on the wall—they’ll cut prices on 13 drugs beginning in 2024. That beats the negotiated terms by two years. The cut are steep: co-pays will be free or $11 on these medicines, down from $30-$50.

AARP says that one in five older adults skip prescriptions or doses to save money. According to Maya Golden’s exclusive report on Axios, these are the drugs you’ll be saving on next year.

➤ Drug Co-Pays Slashed on 13 Drugs: Did Yours Make the List?